HARIM IM: Open Payments
NPI 1992585335 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$830 in 20 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $514 · 2025 $830
Food & beverage: $830
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 5 | $161 |
| SCPHARMACEUTICALS INC. | 1 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $121 |
| Kestra Medical Technology Services, Inc. | 2 | $115 |
| BIOTRONIK INC. | 2 | $111 |
| Novartis Pharmaceuticals Corporation | 3 | $63 |
| Imperative Care, Inc | 2 | $44 |
| Baxter Healthcare | 1 | $30 |
| ABIOMED | 1 | $29 |
| Novo Nordisk Inc | 1 | $18 |
Products named: FUROSCIX, JARDIANCE, Assure WCD, AMVIA EDGE, LEQVIO, AMVUTTRA, SYMPHONY CATHETER, Hillrom - Carnation Ambulatory Monitor.
Industry payments across TX — which companies pay providers there.
